Focal invites everyone to its party

Focal Inc. is looking for the best anti-restenosis compound it can find. And to get it, the privately held company plans a series of non-exclusive agreements to develop pharmaceutical compounds with its FocalGel polymer delivery system.

The Cambridge, Mass., company announced the first agreement, which also is its first corporate partnership, with F. Hoffmann-La Roche Ltd. (Basel, Switzerland) and Hoffmann-La Roche Inc. (Nutley, N.J.). The Hoffmann-La Roche compound hasn't been disclosed, nor have terms of the deal...